| Global burden of cardiovascular diseases and risks, 1990-2022 GA Mensah, V Fuster, CJL Murray, GA Roth, ... Journal of the American College of Cardiology 82 (25), 2350-2473, 2023 | 298 | 2023 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 169 | 2024 |
| Prognostic value of stress hyperglycemia ratio in patients with acute myocardial infarction: a systematic review with bayesian and frequentist meta-analysis P Karakasis, N Stalikas, D Patoulias, K Pamporis, E Karagiannidis, ... Trends in Cardiovascular Medicine, 2023 | 23 | 2023 |
| Safety and efficacy of the new, oral, small-molecule, GLP-1 receptor agonists orforglipron and danuglipron for the treatment of type 2 diabetes and obesity: systematic review … P Karakasis, D Patoulias, K Pamporis, P Stachteas, KI Bougioukas, ... Metabolism, 155710, 2023 | 17 | 2023 |
| Effect of tirzepatide on albuminuria levels and renal function in patients with type 2 diabetes mellitus: A systematic review and multilevel meta‐analysis P Karakasis, D Patoulias, N Fragakis, A Klisic, M Rizzo Diabetes, Obesity and Metabolism 26 (3), 1090-1104, 2024 | 13 | 2024 |
| Risk of subclinical atherosclerosis in patients with antiphospholipid syndrome and subjects with antiphospholipid antibody positivity: a systematic review and meta-analysis P Karakasis, E Lefkou, K Pamporis, V Nevras, KI Bougioukas, AB Haidich, ... Current Problems in Cardiology 48 (6), 101672, 2023 | 11 | 2023 |
| Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 VL Feigin, MD Abate, YH Abate, S Abd ElHafeez, F Abd-Allah, ... The Lancet Neurology 23 (10), 973-1003, 2024 | 10 | 2024 |
| Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction: An overview of 36 systematic reviews P Karakasis, K Pamporis, P Stachteas, D Patoulias, KI Bougioukas, ... Heart Failure Reviews 28 (5), 1033-1051, 2023 | 10 | 2023 |
| Accelerated atherosclerosis and management of cardiovascular risk in autoimmune rheumatic diseases: an updated review P Karakasis, D Patoulias, P Stachteas, E Lefkou, T Dimitroulas, ... Current Problems in Cardiology, 101999, 2023 | 9 | 2023 |
| The effect of sodium-glucose co-transporter-2 inhibitors on markers of subclinical atherosclerosis P Stachteas, P Karakasis, D Patoulias, F Clemenza, N Fragakis, M Rizzo Annals of Medicine 55 (2), 2304667, 2023 | 7 | 2023 |
| The Role of Sodium-Glucose Co-Transporter-2 Inhibitors on Diuretic Resistance in Heart Failure P Stachteas, A Nasoufidou, D Patoulias, P Karakasis, E Karagiannidis, ... International Journal of Molecular Sciences 25 (6), 3122, 2024 | 6 | 2024 |
| Efficacy and safety of once‐weekly versus once‐daily basal insulin analogues in the treatment of type 2 diabetes mellitus: A systematic review and meta‐analysis P Karakasis, D Patoulias, K Pamporis, DS Popovic, P Stachteas, ... Diabetes, Obesity and Metabolism 25 (12), 3648-3661, 2023 | 6 | 2023 |
| Effects of Glucagon-Like Peptide 1 Receptor Agonists on Atrial Fibrillation Recurrence After Catheter Ablation: A Systematic Review and Meta-analysis P Karakasis, N Fragakis, D Patoulias, P Theofilis, G Kassimis, ... Advances in Therapy, 1-8, 2024 | 5 | 2024 |
| Effect of tirzepatide on the risk of diabetic retinopathy in type 2 diabetes DS Popovic, D Patoulias, P Karakasis, T Koufakis, N Papanas Diabetes, Obesity and Metabolism 26 (6), 2497-2500, 2024 | 5 | 2024 |
| Sodium-glucose cotransporter-2 inhibitors in patients with acute coronary syndrome: a modern cinderella? P Karakasis, N Fragakis, K Kouskouras, T Karamitsos, D Patoulias, ... Clinical Therapeutics, 2024 | 4 | 2024 |
| Endothelial protection by sodium-glucose cotransporter 2 inhibitors: a literature review of in vitro and in vivo studies N Mylonas, PE Nikolaou, P Karakasis, P Stachteas, N Fragakis, ... International Journal of Molecular Sciences 25 (13), 7274, 2024 | 4 | 2024 |
| Efficacy of sodium-glucose cotransporter 2 inhibitors in preventing atrial fibrillation recurrence after catheter ablation P Stachteas, P Karakasis, E Karagiannidis, D Patoulias, P Athanasiadou, ... Hellenic journal of cardiology: HJC= Hellenike kardiologike epitheorese …, 2024 | 4 | 2024 |
| Appraisal methods and outcomes of AMSTAR 2 assessments in overviews of systematic reviews of interventions in the cardiovascular field: A methodological study P Karakasis, KI Bougioukas, K Pamporis, N Fragakis, AB Haidich Research Synthesis Methods 15 (2), 213-226, 2024 | 4 | 2024 |
| The Effect of Sodium–Glucose Cotransporter Inhibitors on Renal Function as Adjunctive to Insulin in Adults with Type 1 Diabetes: An Updated Multilevel Meta-analysis of … P Karakasis, DS Popovic, D Patoulias, T Koufakis, N Papanas, N Fragakis, ... Diabetes Therapy 15 (2), 521-532, 2024 | 4 | 2024 |
| The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists in the Management of Obesity-Related Heart Failure with Preserved Ejection Fraction: Benefits beyond What Scales … P Karakasis, N Fragakis, D Patoulias, P Theofilis, M Sagris, T Koufakis, ... Biomedicines 12 (9), 2112, 2024 | 3 | 2024 |
